1-8 of 8
Yoshiko Fujita
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1336: Verification of the effect of human allogeneic iPS cell-derived gene-engineered NK cells (eNK cells HLCN061) on mesothelioma

Seiji Matsumoto, Yoshiko Fujita, Kumiko Goto, Yuka Sato, Fusako Nishigaki, Yasuyuki Higashi, Hironobu Kimura, Kouichi Tamura
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1336.
https://doi.org/10.1158/1538-7445.AM2024-1336
Published: 22 March 2024
View article titled, Abstract 1336: Verification of the effect of human allogeneic iPS cell-derived gene-engineered NK cells (eNK cells HLCN061) on mesothelioma
Journal Articles

Abstract 6408: Anti-tumor immunity evolved by novel titanium peroxide nanoparticles (TiOxNPs) as a radiosensitizer and PD-1 blockade

Yoshiko Fujita, Hikaru Kubota, Chiaki Ogino, Ryohei Sasaki
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6408.
https://doi.org/10.1158/1538-7445.AM2023-6408
Published: 04 April 2023
View article titled, Abstract 6408: Anti-tumor immunity evolved by novel titanium peroxide nanoparticles (TiOxNPs) as a radiosensitizer and PD-1 blockade
Journal Articles

Abstract 2837: A novel radiosensitizer of titanium peroxide nanoparticles (TiOxNPs) through continuous ROS generation

Ryohei Sasaki, Hiroaki Akasaka, Masao Nakayama, Yoshiko Fujita, Hikaru Kubota, Kenta Morita, Mennaallah Hassan, Mohammed Salah, Yuya Nishimura, Naritoshi Mukumoto, Takeaki Ishihara, Daisuke Miyawaki, Chiaki Ogino
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 2837.
https://doi.org/10.1158/1538-7445.AM2023-2837
Published: 04 April 2023
View article titled, Abstract 2837: A novel radiosensitizer of titanium peroxide nanoparticles (TiOxNPs) through continuous ROS generation
Journal Articles

Abstract 4478: Effective prediction of treatment responders with anti-PD-1 antibody in malignant pleural mesothelioma by diversity of peripheral CD8+PD-1+ T cell subpopulation

Seiji Matsumoto, Takaji Matsutani, Yoshiko Fujita, Ryo Takahashi, Takashi Yokoi, Hiroshi Kodama, Yoshie Inao, Kazutaka Kitaura, Tohoru Nakamichi, Akifumi Nakamura, Ayumi Kuroda, Aki Kobayashi, Masaki Hashimoto, Nobuyuki Kondo, Ryuji Suzuki, Koichiro Yamakado, Takashi Kijima, Seiki Hasegawa
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4478.
https://doi.org/10.1158/1538-7445.AM2020-4478
Published: 15 August 2020
View article titled, Abstract 4478: Effective prediction of treatment responders with anti-PD-1 antibody in malignant pleural mesothelioma by diversity of peripheral CD8+PD-1+ T cell subpopulation
Journal Articles

Abstract 2230: Diversity of peripheral CD8+PD-1+ T cells is a novel predictive biomarker for response to anti-PD-1 antibody treatment in lung cancer patients

Seiji Matsumoto, Takaji Matsutani, Yoshiko Fujita, Kazutaka Kitaura, Tohoru Nakamichi, Akifumi Nakamura, Ayumi Kuroda, Masaki Hashimoto, Nobuyuki Kondo, Ryuji Suzuki, Seiki Hasegawa
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2230.
https://doi.org/10.1158/1538-7445.AM2019-2230
Published: 01 July 2019
View article titled, Abstract 2230: Diversity of peripheral CD8+PD-1+ T cells is a novel predictive biomarker for response to anti-PD-1 antibody treatment in lung cancer patients
Journal Articles

Abstract 2581: Antitumor effect of Trametinib, a selective MEK inhibitor, in combination with 4-methylumbelliferone, a hyaluronic acid synthesis inhibitor, in Malignant pleural mesothelioma cell lines

Hiroyuki Cho, Seiji Matsumoto, Yoshiko Fujita, Ayumi Kuroda, Masaki Hashimoto, Teruhisa Takuwa, Toshi Menju, Makoto Sonobe, Nobuyuki Kondo, Hiroshi Date, Seiki Hasegawa
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2581.
https://doi.org/10.1158/1538-7445.AM2015-2581
Published: 01 August 2015
View article titled, Abstract 2581: Antitumor effect of Trametinib, a selective MEK inhibitor, in combination with 4-methylumbelliferone, a hyaluronic acid synthesis inhibitor, in Malignant pleural mesothelioma cell lines
Journal Articles

Abstract 742: Antitumor activity of Trametinib, a MEK1/2 inhibitor, in malignant pleural mesothelioma cells in vitro

Hiroyuki Cho, Seiji Matsumoto, Yoshiko Fujita, Ayumi Kuroda, Masaki Hashimoto, Teruhisa Takuwa, Toshi Menju, Makoto Sonobe, Nobuyuki Kondo, Hiroshi Date, Seiki Hasegawa
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 742.
https://doi.org/10.1158/1538-7445.AM2014-742
Published: 01 October 2014
View article titled, Abstract 742: Antitumor activity of Trametinib, a MEK1/2 inhibitor, in malignant pleural mesothelioma cells <em>in vitro</em>
Journal Articles

Evidence for the Involvement of Transforming Growth Factor α and Epidermal Growth Factor Receptor Autocrine Growth Mechanism in Primary Human Ovarian Cancers in Vitro

Ken-ichiro Morishige, Hirohisa Kurachi, Kyoka Amemiya, Yoshiko Fujita, Toshiya Yamamoto, Akira Miyake, Osamu Tanizawa
Journal: Cancer Research
Cancer Res (1991) 51 (19): 5322–5328.
Published: 01 October 1991
View article titled, Evidence for the Involvement of Transforming Growth Factor α and Epidermal Growth Factor Receptor Autocrine Growth Mechanism in Primary Human Ovarian Cancers <em>in Vitro</em>
Open the PDF for Evidence for the Involvement of Transforming Growth Factor α and Epidermal Growth Factor Receptor Autocrine Growth Mechanism in Primary Human Ovarian Cancers <em>in Vitro</em> in another window